Neoadjuvant cisplatin-based chemotherapy followed by selective bladder preservation chemoradiotherapy (CRT) in muscle-invasive urothelial carcinoma of bladder (MIBC): A combined retrospective analysis of two prospective studies.

被引：0
|
作者：
Hong, Joohyun
Choi, Daeho
Sung, Hyun Hwan
Jeong, Byong Chang
Park, Se Hoon
机构：
[1] Sungkyunkwan Univ, Div Hematol Oncol, Dept Internal Med, Samsung Med Ctr,Sch Med, Seoul, South Korea
[2] Samsung Med Ctr, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[4] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
496
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer
    Philip H. Kim
    Matthew Kent
    Philip Zhao
    John P. Sfakianos
    Dean F. Bajorin
    Bernard H. Bochner
    Guido Dalbagni
    World Journal of Urology, 2014, 32 : 453 - 459
  • [22] The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer
    Kim, Philip H.
    Kent, Matthew
    Zhao, Philip
    Sfakianos, John P.
    Bajorin, Dean F.
    Bochner, Bernard H.
    Dalbagni, Guido
    WORLD JOURNAL OF UROLOGY, 2014, 32 (02) : 453 - 459
  • [23] Feasibility of Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Patients With Diminished Renal Function
    Koshkin, Vadim S.
    Barata, Pedro C.
    Rybicki, Lisa A.
    Zahoor, Haris
    Almassi, Nima
    Redden, Alicia M.
    Fergany, Amr F.
    Kaouk, Jihad
    Haber, Georges-Pascal
    Stephenson, Andrew J.
    Ornstein, Moshe C.
    Gilligan, Timothy
    Garcia, Jorge A.
    Rini, Brian, I
    Grivas, Petros
    CLINICAL GENITOURINARY CANCER, 2018, 16 (04) : E879 - E892
  • [24] Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer
    Li, Roger
    Nocera, Luigi
    Rose, Kyle M.
    Raggi, Daniele
    Naidu, Shreyas
    Mercinelli, Chiara
    Cigliola, Antonio
    Tateo, Valentina
    Patane, Damiano
    Grass, G. Daniel
    Gilbert, Scott M.
    Sexton, Wade J.
    Bandini, Marco
    Moschini, Marco
    Briganti, Alberto
    Montorsi, Francesco
    Spiess, Philippe E.
    Necchi, Andrea
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (03): : 614 - 624
  • [25] Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer
    Stangl-Kremser, Judith
    Mari, Andrea
    D'Andrea, David
    Kimura, Shoji
    Resch, Irene
    Shariat, Shahrokh F.
    Klatte, Tobias
    UROLOGIA INTERNATIONALIS, 2018, 101 (02) : 197 - 200
  • [26] NETOS: A personalized approach of neoadjuvant therapy, including INCB099280 monotherapy and bladder preservation, for muscle-invasive urothelial bladder carcinoma (MIBC) with ctDNA monitoring
    Necchi, Andrea
    Tateo, Valentina
    Cigliola, Antonio
    Mercinelli, Chiara
    Patane, Damiano
    Moschini, Marco
    Colombo, Renzo
    Colecchia, Maurizio
    Brembilla, Giorgio
    Briganti, Alberto
    Montorsi, Francesco
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] PDL1 status in muscle-invasive urothelial carcinoma in the context of neoadjuvant cisplatin-based chemotherapy.
    Liu, Jen-Jane
    Baras, Alexander S.
    Gandhi, Nilay M.
    Guner, Gunes
    Munari, Enrico
    Faraj, Sheila
    Taube, Janis M.
    Schoenberg, Mark
    Hahn, Noah M.
    Drake, Charles G.
    Netto, George J.
    Bivalacqua, Trinity
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [28] Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer
    Plimack, Elizabeth R.
    Dunbrack, Roland L.
    Brennan, Timothy A.
    Andrake, Mark D.
    Zhou, Yan
    Serebriiskii, Ilya G.
    Slifker, Michael
    Alpaugh, Katherine
    Dulaimi, Essel
    Palma, Norma
    Hoffman-Censits, Jean
    Bilusic, Marijo
    Wong, Yu-Ning
    Kutikov, Alexander
    Viterbo, Rosalia
    Greenberg, Richard E.
    Chen, David Y. T.
    Lallas, Costas D.
    Trabulsi, Edouard J.
    Yelensky, Roman
    McConkey, David J.
    Miller, Vincent A.
    Golemis, Erica A.
    Ross, Eric A.
    EUROPEAN UROLOGY, 2015, 68 (06) : 959 - 967
  • [29] IDENTIFICATION OF MOLECULAR BIOMARKERS OF CISPLATIN-BASED CHEMOSENSITIVITY IN PATIENTS UNDERGOING NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
    Shah, Paras
    Kozel, Zachary
    Lee, Annette
    Korsunsky, Ilya
    Shih, Andrew
    Yaskiv, Oksana
    Vira, Manish
    Bradley, Thomas
    Zhu, Xinhua
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1196 - E1197
  • [30] Neoadjuvant cisplatin-based chemotherapy in "primary" and "secondary" muscle-invasive bladder cancer-is it a surrogate for molecular subtypes?
    Szarvas, Tibor
    Olah, Csilla
    Reis, Henning
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S176 - S179
12345